Actively Identifying Limiting Factors in Speed to Launch Drug Products

Complimentary
Learning Level: Advanced
Time: 1000 - 1130 EST 
Session Length: 1.5 hour

In the dynamic landscape of drug manufacturing, the development and launch of injectable drugs are often hindered by limiting factors that impede their timely market entry. This webinar aims t to provide pharmaceutical professionals, researchers, and stakeholders with an overview of the challenges and strategies involved in accelerating the launch of injectable drugs.

During this webinar, our experts will delve into a range of topics including regulatory hurdles, formulation complexities, supply chain considerations, and market access challenges that can slow down the path to commercialization. Attendees will gain insights into innovative approaches, real work practices, and case studies that have successfully expedited the launch of injectable drugs in the global market.

Join us as we bring together thought leaders, industry veterans, and regulatory experts to share their experiences and strategies for mitigating the limiting factors in speed to launch for injectable drugs. By the end of the webinar, participants will be equipped with the knowledge and tools needed to navigate the intricate process of drug development, ensuring faster access to life saving and life improving injectable medications. Don't miss the opportunity to advance your understanding of this critical aspect of the pharmaceutical industry.

Learning Objectives

  1. Steps to take to facilitate a fast execution of an Aseptic filling project.
  2. Identify the items (often missed) that could lead to lost time in execution and qualification of a new Aseptic Filling project.
  3. Learn from a large group of experienced people with Sterile Products background about the things that are often missed in projects.

Register Now!


Speakers

Massimiliano Cesarini
Managing Director - Life Sciences
Omnia Technologies
Jason S. Collins, AIA
Director of Process Architecture
IPS-Integrated Project Services, LLC
Richard Denk
Senior Consultant Aseptic Processing & Containment
SKAN AG
Matthew Gorton
Director of Business Development
GBA Life Sciences
Christa Myers
Sr. Fellow - Aseptic and Sterile Products, Vertical Market Leader
CRB
Ryan Waldhart
Manager of MSAT (Manager of Manufacturing Science and Technology)
Grand River Aseptic Manufacturing